A Clinical Study of Lupron Depot in the Treatment of Women with Alzheimer's Disease: Preservation of Cognitive Function in Patients Taking an Acetylcholinesterase Inhibitor and Treated with High Dose Lupron Over 48 Weeks

Manuscript Number: 


Craig S. Atwood, Richard L. Bowen, George Perry, Mark A. Smith, Chengjie Xiong


Craig S. Atwood

  • Nothing to Disclose

Richard L. Bowen

  • Equity:
    Own stock in and was employed by Voyager Pharmaceutical Corp. which sponsored the study but has since filed for bankruptcy and is no longer in business.

George Perry

  • Nothing to Disclose

Mark A. Smith

  • Nothing to Disclose

Chengjie Xiong

  • Nothing to Disclose